For in vitro diagnostic use. Others Elecsys HSV-2 IgG IVD Elecsys® HSV-2 IgG CPS_000485 08948909190 HSV-2 IgG Elecsys E2G 100 V2 Elecsys HSV-2 IgG 07613336170687 Reagents, kits 100 tests cobas e 411/601/602 true 08948887190 HSV-2 IgG Elecsys cobas e 100 V2 Elecsys HSV-2 IgG 07613336170670 Reagents, kits 100 tests cobas e 411/601/602 true 08948909500 Elecsys HSV-2 IgG en 1 FF00000004B4B60E FF00000004B4B50E 08948909190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑2 in human serum and plasma. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08948887500 Elecsys HSV-2 IgG en 1 FF00000004B4B00E FF00000004B4B00E 08948887190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgG class antibodies to HSV‑2 in human serum and plasma. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en